273 related articles for article (PubMed ID: 17641968)
1. The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care.
Manns BJ; Mendelssohn DC; Taub KJ
Int J Health Care Finance Econ; 2007 Sep; 7(2-3):149-69. PubMed ID: 17641968
[TBL] [Abstract][Full Text] [Related]
2. End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF).
Dor A; Pauly MV; Eichleay MA; Held PJ
Int J Health Care Finance Econ; 2007 Sep; 7(2-3):73-111. PubMed ID: 17653860
[TBL] [Abstract][Full Text] [Related]
3. International study of health care organization and financing: development of renal replacement therapy in Germany.
Kleophas W; Reichel H
Int J Health Care Finance Econ; 2007 Sep; 7(2-3):185-200. PubMed ID: 17701342
[TBL] [Abstract][Full Text] [Related]
4. International Study of Health Care Organization and Financing for end-stage renal disease in France.
Durand-Zaleski I; Combe C; Lang P
Int J Health Care Finance Econ; 2007 Sep; 7(2-3):171-83. PubMed ID: 17680359
[TBL] [Abstract][Full Text] [Related]
5. International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality.
Pontoriero G; Pozzoni P; Vecchio LD; Locatelli F
Int J Health Care Finance Econ; 2007 Sep; 7(2-3):201-15. PubMed ID: 17641969
[TBL] [Abstract][Full Text] [Related]
6. The organization and financing of end-stage renal disease treatment in Japan.
Fukuhara S; Yamazaki C; Hayashino Y; Higashi T; Eichleay MA; Akiba T; Akizawa T; Saito A; Port FK; Kurokawa K
Int J Health Care Finance Econ; 2007 Sep; 7(2-3):217-31. PubMed ID: 17690980
[TBL] [Abstract][Full Text] [Related]
7. The organization and financing of dialysis and kidney transplantation services in New Zealand.
Ashton T; Marshall MR
Int J Health Care Finance Econ; 2007 Dec; 7(4):233-52. PubMed ID: 17638073
[TBL] [Abstract][Full Text] [Related]
8. The organization and financing of end-stage renal disease in Spain.
Luño J
Int J Health Care Finance Econ; 2007 Dec; 7(4):253-67. PubMed ID: 17602295
[TBL] [Abstract][Full Text] [Related]
9. The financing and organization of medical care for patients with end-stage renal disease in Sweden.
Wikström B; Fored M; Eichleay MA; Jacobson SH
Int J Health Care Finance Econ; 2007 Dec; 7(4):269-81. PubMed ID: 17657602
[TBL] [Abstract][Full Text] [Related]
10. International Study of Health Care Organization and Financing of renal services in England and Wales.
Nicholson T; Roderick P
Int J Health Care Finance Econ; 2007 Dec; 7(4):283-99. PubMed ID: 17653861
[TBL] [Abstract][Full Text] [Related]
11. Belgium's mixed private/public health care system and its impact on the cost of end-stage renal disease.
Van Biesen W; Lameire N; Peeters P; Vanholder R
Int J Health Care Finance Econ; 2007 Sep; 7(2-3):133-48. PubMed ID: 17638074
[TBL] [Abstract][Full Text] [Related]
12. The organization and financing of kidney dialysis and transplant care in the United States of America.
Hirth RA
Int J Health Care Finance Econ; 2007 Dec; 7(4):301-18. PubMed ID: 17602296
[TBL] [Abstract][Full Text] [Related]
13. Canada's health system.
Davies BJ
Croat Med J; 1999 Jun; 40(2):280-6. PubMed ID: 10234072
[TBL] [Abstract][Full Text] [Related]
14. Reduction in ESRD reimbursement rate: identifying research priorities and quality indicators.
Parker J
ANNA J; 1990 Apr; 17(2):147-54. PubMed ID: 2183724
[TBL] [Abstract][Full Text] [Related]
15. The organization and funding of the treatment of end-stage renal disease in Australia.
Harris A
Int J Health Care Finance Econ; 2007 Sep; 7(2-3):113-32. PubMed ID: 17763938
[TBL] [Abstract][Full Text] [Related]
16. Current status of end-stage renal disease care in South Asia.
Jha V
Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871
[TBL] [Abstract][Full Text] [Related]
17. Risk factor and cost accounting analysis for dialysis patients in Taiwan.
Su BG; Tsai KL; Yeh SH; Ho YY; Liu SY; Rivers PA
Health Serv Manage Res; 2010 May; 23(2):84-93. PubMed ID: 20424276
[TBL] [Abstract][Full Text] [Related]
18. What can we learn from the U.S. expanded end-stage renal disease bundle?
Chambers JD; Weiner DE; Bliss SK; Neumann PJ
Health Policy; 2013 May; 110(2-3):164-71. PubMed ID: 23419419
[TBL] [Abstract][Full Text] [Related]
19. An overview of the Canadian health care experience.
Gold JH; Hector RI; Grunberg F
Hosp Community Psychiatry; 1986 Nov; 37(11):1115-8. PubMed ID: 3096871
[TBL] [Abstract][Full Text] [Related]
20. The direction of end-stage renal disease reimbursement in the United States.
Lockridge RS
Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
